These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9225710)

  • 1. Treatment with buspirone in a patient with autism.
    McCormick LH
    Arch Fam Med; 1997; 6(4):368-70. PubMed ID: 9225710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone for Comorbid Anxiety in Autism.
    Gupta M; Gupta N; Moll J; Ramar D
    Prim Care Companion CNS Disord; 2023 Mar; 25(2):. PubMed ID: 36946573
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized double-blind placebo-controlled clinical trial of adjuvant buspirone for irritability in autism.
    Ghanizadeh A; Ayoobzadehshirazi A
    Pediatr Neurol; 2015 Jan; 52(1):77-81. PubMed ID: 25451017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.
    Handen BL; Johnson CR; Lubetsky M
    J Autism Dev Disord; 2000 Jun; 30(3):245-55. PubMed ID: 11055460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An 8-week, randomized controlled trial of atomoxetine, atomoxetine plus buspirone, or placebo in adults with ADHD.
    Sutherland SM; Adler LA; Chen C; Smith MD; Feltner DE
    J Clin Psychiatry; 2012 Apr; 73(4):445-50. PubMed ID: 22313788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
    Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
    Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonidine treatment of hyperactive and impulsive children with autistic disorder.
    Jaselskis CA; Cook EH; Fletcher KE; Leventhal BL
    J Clin Psychopharmacol; 1992 Oct; 12(5):322-7. PubMed ID: 1479049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buspirone in ADHD with ODD.
    Gross MD
    J Am Acad Child Adolesc Psychiatry; 1995 Oct; 34(10):1260. PubMed ID: 7592261
    [No Abstract]   [Full Text] [Related]  

  • 9. An open trial of buspirone in the treatment of attention-deficit disorder.
    Niederhofer H
    Hum Psychopharmacol; 2003 Aug; 18(6):489-92. PubMed ID: 12923830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effect of buspirone in autistic children.
    Realmuto GM; August GJ; Garfinkel BD
    J Clin Psychopharmacol; 1989 Apr; 9(2):122-5. PubMed ID: 2723129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of autism with low-dose phenytoin: a case report.
    Bird PD
    J Med Case Rep; 2015 Jan; 9():8. PubMed ID: 25592685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P; Rouillon F; Pouget D
    Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of two dosing regimens of buspirone in the treatment of outpatients with persistent anxiety.
    Sramek JJ; Frackiewicz EJ; Cutler NR
    Clin Ther; 1997; 19(3):498-506. PubMed ID: 9220214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo double-blind pilot study of dextromethorphan for problematic behaviors in children with autism.
    Woodard C; Groden J; Goodwin M; Bodfish J
    Autism; 2007 Jan; 11(1):29-41. PubMed ID: 17175572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder.
    Lader M; Scotto JC
    Psychopharmacology (Berl); 1998 Oct; 139(4):402-6. PubMed ID: 9809861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Weiss M; Hechtman L; Turgay A; Jain U; Quinn D; Ahmed TS; Yates T; Reiz JL; Donnelly GA; Harsanyi Z; Darke AC
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):675-88. PubMed ID: 17979587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.
    Kolmen BK; Feldman HM; Handen BL; Janosky JE
    J Am Acad Child Adolesc Psychiatry; 1995 Feb; 34(2):223-31. PubMed ID: 7896655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST; Park JH; Kim M
    Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buspirone for autistic disorder in a woman with an intellectual disability.
    Brahm NC; Fast GA; Brown RC
    Ann Pharmacother; 2008 Jan; 42(1):131-7. PubMed ID: 18056831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind methylphenidate trials: practical, useful, and highly endorsed by families.
    Kent MA; Camfield CS; Camfield PR
    Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1292-6. PubMed ID: 10591309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.